| Date Filed | Type | Description |
| 06/08/2023 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 45,000 options to buy
@ $1.2, valued at
$54k
|
|
| 05/05/2023 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on Vericel Corp|
Txns:
| Granted 8,000 options to buy
@ $32.12, valued at
$257k
Granted 3,200 restricted stock units
@ $0 |
|
| 06/22/2022 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 10,000 options to buy
@ $1.78, valued at
$17.8k
|
|
| 06/09/2022 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 13,700 shares
@ $0
Granted 20,100 options to buy
@ $0.45, valued at
$9k
|
|
| 06/07/2022 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 4,567 shares
@ $0.362, valued at
$1.7k
|
|
| 05/18/2022 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on CONTRAFECT Corp|
Txns:
| Granted 42,000 options to buy
@ $3.35, valued at
$140.7k
|
|
| 05/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2021 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on Vericel Corp|
Txns:
| Sold 5,000 shares
@ $39.171, valued at
$195.9k
Exercised 5,000 options to buy
@ $3.74, valued at
$18.7k
|
|
| 10/28/2021 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on Vericel Corp|
Txns:
| Sold 5,000 shares
@ $50.574, valued at
$252.9k
Exercised 5,000 options to buy
@ $3.74, valued at
$18.7k
|
|
| 10/01/2021 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on Vericel Corp|
Txns:
| Sold 5,000 shares
@ $48.851, valued at
$244.3k
Exercised 5,000 options to buy
@ $3.74, valued at
$18.7k
|
|
| 06/21/2021 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 10,000 options to buy
@ $7.51, valued at
$75.1k
|
|
| 06/09/2021 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 4,567 shares
@ $3.3202, valued at
$15.2k
|
|
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2021 |
4/A
| GILMAN STEVEN C (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 55,000 options to buy
@ $0.73, valued at
$40.2k
|
|
| 12/23/2020 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Bought 4,000 shares
@ $6.25, valued at
$25k
Granted 2,000 warrants
@ $7.33, valued at
$14.7k
Granted 2,000 warrants
@ $8.25, valued at
$16.5k
|
|
| 10/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2020 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 45,000 options to buy
@ $0.73, valued at
$32.9k
|
|
| 06/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2020 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 13,700 shares
@ $0
Sold 4,567 shares
@ $12.08, valued at
$55.2k
Granted 20,100 options to buy
@ $11.96, valued at
$240.4k
|
|
| 05/18/2020 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on CONTRAFECT Corp |
| 05/01/2020 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on Vericel Corp|
Txns:
| Exercised 1,750 shares
@ $0
Exercised 1,750 restricted stock units
@ $14.56, valued at
$25.5k
Granted 13,125 options to buy
@ $14.56, valued at
$191.1k
Granted 1,750 restricted stock units
@ $0 |
|
| 11/22/2019 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Bought 5,800 shares
@ $3.43, valued at
$19.9k
|
|
| 08/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2019 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC|
Txns:
| Granted 25,000 options to buy
@ $12.64, valued at
$316k
Exercised 4,356 restricted stock units
@ $0 |
|
| 06/20/2019 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 45,000 options to buy
@ $1.29, valued at
$58.1k
|
|
| 06/10/2019 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 13,700 shares
@ $0
Granted 20,100 options to buy
@ $4.23, valued at
$85k
|
|
| 05/29/2019 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on CONTRAFECT Corp |
| 05/03/2019 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on Vericel Corp|
Txns:
| Sold 7,500 shares
@ $16.8126, valued at
$126.1k
Exercised 7,500 options to buy
@ $2.76, valued at
$20.7k
Granted 13,125 options to buy
@ $16.62, valued at
$218.1k
Granted 1,750 restricted stock units
@ $0 |
|
|